- Home
- Mutual Funds
- Motilal Oswal Mutual Fund
- Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
Fund Overview of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
-
₹40.0 CrAUM
-
₹12.16NAV
-
0.76%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 12.97% | NA | 6.12% |
| 6 Months | 20.92% | NA | 12.92% |
| 1 Year | 10.47% | 10.47% | 6.04% |
Asset Allocation
equities
100.29%Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth is one Equity mutual fund offered by Motilal Oswal Mutual Fund. Launched on 19 Nov 2024, the fund aims Return that corresponds to the returns of the Nifty MidSmall Healthcare Total Return Index, subject to tracking error. Long term capital growth. It manages assets worth ₹40.0 crore as on Tue Jun 30, 2026. The expense ratio stands at 0.76%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
The portfolio allocation consists of 100.29% in equities.Managed by Swapnil P Mayekar, it has delivered a return of 10.47% in the last year, a total return since inception of 12.38%.
Considering individual goals investors often review best sip as part of their overall investment planning.
Fund Details
|
|
Compare Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth with other mutual funds in the same category
Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
SBI Healthcare Opportunities Fund Direct Plan-growth
SBI Healthcare Opportunities Fund Direct Plan-idcw
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
SBI Healthcare Opportunities Fund Direct Plan-growth  |
₹4,998 | 2.56% | 16.83% | 13.52% | 23.77% | 17.21% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,998 | 2.56% | 16.83% | 13.52% | 23.77% | 17.21% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,625 | 0.41% | 11.45% | 6.29% | 24.54% | 16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,625 | 0.41% | 11.45% | 6.29% | 24.54% | 16.25% |
| SBI Healthcare Opportunities Fund-growth |
₹4,998 | 2.48% | 16.55% | 12.39% | 22.49% | 15.98% |
| SBI Healthcare Opportunities Fund-idcw |
₹4,998 | 2.48% | 16.55% | 12.39% | 22.49% | 15.98% |
| DSP Healthcare Fund Direct-growth |
₹3,514 | 1.99% | 14.55% | 8.22% | 21.75% | 15.57% |
| DSP Healthcare Fund Direct-idcw |
₹3,514 | 1.99% | 14.55% | 8.22% | 21.75% | 15.57% |
| Mirae Asset Healthcare Fund Direct-growth |
₹3,253 | 2.83% | 12.26% | 13.09% | 23.96% | 15.37% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹3,253 | 2.83% | 12.26% | 13.09% | 23.96% | 15.37% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Motilal Oswal Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Motilal Oswal Bse Healthcare Etf-growth
|
₹42 | 1.87% | 13.52% | 19.95% | 9.63% | 23.00% |
|
Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth
|
₹40 | 2.31% | 12.86% | 20.65% | 9.97% | - |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹9,044 | ₹556.11 | 18.85% | 12.13% | 14.69% |
| Nippon India Pharma Fund Direct-growth |
₹9,044 | ₹625.01 | 19.92% | 13.15% | 15.71% |
| Nippon India Pharma Fund-idcw |
₹9,044 | ₹120.09 | 18.85% | 12.13% | 14.69% |
| Nippon India Pharma Fund Direct-idcw |
₹9,044 | ₹171.05 | 19.92% | 13.15% | 15.71% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,625 | ₹42.91 | 23.49% | 15.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,625 | ₹46.62 | 24.54% | 16.25% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,625 | ₹25.03 | 23.49% | 15.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,625 | ₹28.15 | 24.54% | 16.25% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,998 | ₹574.88 | 23.77% | 17.21% | 14.47% |
| SBI Healthcare Opportunities Fund-growth |
₹4,998 | ₹496.93 | 22.49% | 15.98% | 13.23% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Max Healthcare Institute Ltd | Healthcare | 15.07% | ₹4.28 Cr |
| Laurus Labs Ltd | Healthcare | 9.31% | ₹3.72 Cr |
| Laurus Labs Ltd | Healthcare | 9.31% | ₹3.72 Cr |
| Laurus Labs Ltd | Healthcare | 9.31% | ₹3.72 Cr |
| Laurus Labs Ltd | Healthcare | 9.31% | ₹3.72 Cr |
| Lupin Ltd | Healthcare | 9.26% | ₹3.71 Cr |
| Lupin Ltd | Healthcare | 9.26% | ₹3.71 Cr |
| Lupin Ltd | Healthcare | 9.26% | ₹3.71 Cr |
| Lupin Ltd | Healthcare | 9.26% | ₹3.71 Cr |
| Lupin Ltd | Healthcare | 9.15% | ₹3.17 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.86% | ₹3.15 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.86% | ₹3.15 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.86% | ₹3.15 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.86% | ₹3.15 Cr |
| Laurus Labs Ltd | Healthcare | 8.82% | ₹3.06 Cr |
| Lupin Ltd | Healthcare | 9.88% | ₹3.02 Cr |
| Lupin Ltd | Healthcare | 10.67% | ₹2.96 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.91% | ₹2.93 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.91% | ₹2.93 Cr |
| Lupin Ltd | Healthcare | 10.25% | ₹2.91 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹574.88 | 23.77% | 17.21% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹399.41 | 23.77% | 17.21% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹46.62 | 24.54% | 16.25% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹28.15 | 24.54% | 16.25% | - |
| SBI Healthcare Opportunities Fund-growth |
₹496.93 | 22.49% | 15.98% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹313.04 | 22.49% | 15.98% | - |
| DSP Healthcare Fund Direct-growth |
₹48.48 | 21.75% | 15.57% | - |
| DSP Healthcare Fund Direct-idcw |
₹28.04 | 21.75% | 15.57% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹49.93 | 23.96% | 15.37% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹30.07 | 23.96% | 15.37% | - |
growth is based on 5Y returns of the funds
Frequently Asked Questions
Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
What is the current AUM of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
As of Tue Jun 30, 2026, Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth manages assets worth ₹40.0 crore
How has Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth performed recently?
- 3 Months: 12.97%
- 6 Months: 20.92%
What is the long-term performance of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
- Since Inception: 12.38%
What is the portfolio composition of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
Equity: 100.29%, Others: -0.30%.
Who manages Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth is managed by Swapnil P Mayekar from Motilal Oswal Mutual Fund.
What is the market-cap allocation of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
Mid Cap: 67.70%, Small Cap: 32.30%.
Which are the top companies Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth has invested in?
- Max Healthcare Institute Ltd – 15.07% of the fund's portfolio
- Laurus Labs Ltd – 9.31% of the fund's portfolio
- Laurus Labs Ltd – 9.31% of the fund's portfolio
- Laurus Labs Ltd – 9.31% of the fund's portfolio
- Laurus Labs Ltd – 9.31% of the fund's portfolio
Which are the major sectors Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth focuses on?
- Healthcare – 189.37% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
